1. Home
  2. Session 7 : Maximizing EGFR TKI treatment in NSCLC
Skip to main content
eLearning on BoehringerOne
The Disease

Gio Talk

 

Session 7 : Maximizing EGFR TKI treatment in NSCLC

Tối ưu hóa điều trị EGFR TKI trong điều trị UTPKTBN - 08 Mins 51 Secs | PC-VN-103022

Satoru Miura, M.D., Ph.D.

Presenter

Prof. Kenchil Park

Division of Hematology-Oncology,
Department of Medicine, Samsung
Medical Center

Báo cáo viên

Giáo sư Kenchil Park

Khoa Huyết học-Ung bướu, Khoa Y,
Trung tâm Y khoa Samsung